Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Grieshaber-Bouyer

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Der Internist|April 26, 2020
[Biosimilars: opportunities and risks]R Grieshaber-Bouyer, H-M Lorenz
The Journal of Experimental Medicine|December 31, 2025
T cell engagers emerge as a compelling therapeutic modalityP A Baeuerle, K Sauer, R Grieshaber-Bouyer, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Der Internist|April 26, 2020
[Biosimilars: opportunities and risks]R Grieshaber-Bouyer, H-M Lorenz
The Journal of Experimental Medicine|December 31, 2025
T cell engagers emerge as a compelling therapeutic modalityP A Baeuerle, K Sauer, R Grieshaber-Bouyer, et al.
Pageof 1